TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure

被引:348
作者
Kleinbongard, Petra [1 ]
Heusch, Gerd [1 ]
Schulz, Rainer [1 ]
机构
[1] Univ Klinikum Essen, Inst Pathophysiol, D-45122 Essen, Germany
关键词
Cardioprotection; Heart failure; Myocardial function; Myocardial ischemia; Myocardial reperfusion; Remodeling; Tumor necrosis factor alpha; TNF alpha antagonists; Vascular function; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; LEFT-VENTRICULAR DYSFUNCTION; VASCULAR SMOOTH-MUSCLE; MITOCHONDRIAL PERMEABILITY TRANSITION; IDIOPATHIC DILATED CARDIOMYOPATHY; ENDOTHELIAL BARRIER DYSFUNCTION; ADULT FELINE MYOCARDIUM; APOE-DEFICIENT MICE;
D O I
10.1016/j.pharmthera.2010.05.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
TNF alpha is crucially involved in the pathogenesis and progression of atherosclerosis, myocardial ischemia/reperfusion injury and heart failure. The formation and release of TNF alpha and its downstream signal transduction cascade following activation of its two receptor subtypes is characterized, with special emphasis on the cardiovascular system. In the vasculature, TNF alpha alters endothelial and vascular smooth muscle cell function as well as endothelial cell blood cell interaction; the importance of such alterations for vascular dysfunction, the initiation and progression of atherosclerosis are discussed. In the myocardium, TNF alpha contributes to reversible and irreversible ischemia/reperfusion injury, post-myocardial infarction remodeling and heart failure development. Simultaneously, TNF alpha also contributes to cardioprotection by ischemic conditioning. Emphasis is placed on such ambivalent (detrimental vs. beneficial) role of TNF alpha, which appears to be dose- and time-dependent and in part related to the activation of the specific receptor subtype. Given the ambivalent role of TNF alpha and its receptors, it is not surprising that clinical trials using compounds that antagonize TNF alpha revealed ambiguous and largely disappointing results in cardiovascular disease, notably in heart failure. Future perspectives to antagonize and/or potentially recruit TNF alpha in the cardiovascular system are critically discussed. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:295 / 314
页数:20
相关论文
共 393 条
  • [21] Endotoxin and ischemic preconditioning:: TNF-α concentration and myocardial infarct development in rabbits
    Belosjorow, S
    Schulz, R
    Dörge, H
    Schade, FU
    Heusch, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 277 (06): : H2470 - H2475
  • [22] TNF-α antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits
    Belosjorow, S
    Bolle, I
    Duschin, A
    Heusch, G
    Schulz, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (03): : H927 - H930
  • [23] Influence of TNF-α and biomechanical stress on endothelial anti- and prothrombotic genes
    Bergh, N.
    Ulfhammer, E.
    Glise, K.
    Jern, S.
    Karlsson, L.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 385 (03) : 314 - 318
  • [24] New insights into the pathological role of TNF-α in early cardiac dysfunction and subsequent heart failure after infarction in rats
    Berthonneche, C
    Sulpice, T
    Boucher, F
    Gouraud, L
    de Leiris, J
    O'Connor, SE
    Herbert, JM
    Janiak, P
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (01): : H340 - H350
  • [25] PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE DURING EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES - EFFECT OF INTERVENTIONS IN THE CYTOKINE AND COAGULATION CASCADES
    BIEMOND, BJ
    LEVI, M
    TENCATE, H
    VANDERPOLL, T
    BULLER, HR
    HACK, CE
    TENCATE, JW
    [J]. CLINICAL SCIENCE, 1995, 88 (05) : 587 - 594
  • [26] Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis
    Bilsborough, William
    Keen, Helen
    Taylor, Andrew
    O'Driscoll, Gerard J.
    Arnolda, Leonard
    Green, Daniel J.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1125 - 1131
  • [27] A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells
    Black, RA
    Rauch, CT
    Kozlosky, CJ
    Peschon, JJ
    Slack, JL
    Wolfson, MF
    Castner, BJ
    Stocking, KL
    Reddy, P
    Srinivasan, S
    Nelson, N
    Boiani, N
    Schooley, KA
    Gerhart, M
    Davis, R
    Fitzner, JN
    Johnson, RS
    Paxton, RJ
    March, CJ
    Cerretti, DP
    [J]. NATURE, 1997, 385 (6618) : 729 - 733
  • [28] Lesion progression and plaque composition are not altered in older apoE-/- mice lacking tumor necrosis factor-α receptor p55
    Blessing, E
    Bea, F
    Kuo, CC
    Campbell, LA
    Chesebro, B
    Rosenfeld, ME
    [J]. ATHEROSCLEROSIS, 2004, 176 (02) : 227 - 232
  • [29] EFFECTS OF INHIBITION OF NITRIC-OXIDE SYNTHESIS ON TNF-ALPHA SERUM LEVELS IN ESCHERICHIA-COLI ENDOTOXEMIC RATS
    BOCZKOWSKI, J
    PHILIP, I
    TEDGUI, A
    BERNARD, C
    MERVAL, R
    DESMONTS, JM
    AUBIER, M
    [J]. LIFE SCIENCES, 1995, 57 (13) : PL147 - PL152
  • [30] The myocardial JAK/STAT pathway: From protection to failure
    Boengler, Kerstin
    Hilfiker-Kleiner, Denise
    Drexler, Helmut
    Heusch, Gerd
    Schulz, Rainer
    [J]. PHARMACOLOGY & THERAPEUTICS, 2008, 120 (02) : 172 - 185